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Background
To investigate implications for management of Vitamin
D deficiency in HIV disease. Vitamin D, the prohor-
mone, is important in bone metabolism, renal disease,
immune function and recently has been studied for its
relationship to cardiovascular disease and cancer. Var-
ious reports have noted the prevalence of Vitamin D
deficiency among HIV infected individuals.
Methods
Case studies of 17 HIV/AIDS patients in two commu-
nity-based private practices in San Francisco caring for
nearly 1000 HIV patients were initiated in 2009. Charts
were reviewed for serum 25-(OH) Vitamin D, ionized
calcium (Ca), parathyroid hormone (PTH), CD4 cell
count, viral load, and lipid levels. Age, race, gender,
current antiretroviral treatment, significant concomitant
diseases and results of bone mineral density by DEXA
scans were noted. We defined Vitamin D insufficiency or
suboptimal levels as <30 ng/dl, deficiency as <20 ng/dl
and severe deficiency as <10 ng/dl. Levels of 25-(OH)
Vitamin D after at least 3 months of replacement with
800 IU of Vitamin D were noted when available.
Results
65% were older than 50, 29% were between 40 and 50,
and 6% were younger than 40. 76% were White, 12% were
Hispanics, 6% were African-American and 6% were Pacific
Islander. All were male except for one male to female
transgender patient. All patients except one (Elite Control-
ler on no meds) were on antiretroviral therapy and 100%
were virologically suppressed at <75. CD4 counts ranged
from 174 to 1058 with 69% > 350. All were on well
balanced diets. Overall, 76% had 25-(OH) Vitamin D levels
of less than 30 with 12% severely deficient, and with the
lowest level of 8.9 in a 37 year old patient. 2 patients, both
over 60 years of age had normal levels.
Discussion
A significant number of these patients (76%) had insuffi-
cient or suboptimal levels of Vitamin D. It is clear that
Vitamin D is obtained from sun exposure, the diet or
from supplements. What is unclear is what are the
causes of the deficiency and what is the association of
this deficiency with HIV itself, antiretroviral treatment
or perhaps, premature aging in a chronically infected
population.
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